Motif Neurotech Secures FDA Approval for First Clinical Trial of Depression-Focused BCI Motif Neurotech, a pioneering brain-computer interface company focused on mental health innovation, has reached a major milestone with regulatory clearance from the U.S. Food and Drug Administration to…
Seaport Therapeutics Appoints Intra-Cellular Therapies Founder Dr. Sharon Mates to Board Seaport Therapeutics has strengthened its leadership team with the appointment of Dr. Sharon Mates to its Board of Directors, marking a significant step forward for the Boston-based clinical-stage company…
vVARDIS Secures Apollo Investment, Reaches Unicorn Valuation vVARDIS Holding AG, an emerging leader in dental medtech innovation, has announced a strategic minority investment from funds managed by Apollo. This development marks a significant milestone for the company as it accelerates…
Genentech Teams Up With Damon Wayans and diaTribe for ‘All Eyes on DME’ Campaign on Diabetes Vision Loss Genentech, a member of the Roche Group, has launched a new awareness initiative titled “All Eyes on DME,” a campaign designed to…
Fertility Specialists of Texas and First Fertility Highlight Expertise at ASPIRE 2026 Fertility Specialists of Texas and First Fertility, recognized leaders in advanced reproductive healthcare, are strengthening their position at the forefront of innovation through new research presented at the…
DCA Plans Deal to Boost Growth and Finances Dental Care Alliance (DCA), one of the largest dental support organizations (DSOs) in the United States, has announced a significant strategic transaction aimed at strengthening its financial foundation and positioning the company…
Hippocratic AI Expands via Health Partnerships to Improve Outcomes Hippocratic AI, headquartered in Palo Alto, California, continues to accelerate its mission of transforming healthcare delivery through the responsible use of generative artificial intelligence. The company recently announced a new phase…
Nutex Health Sets Q1 2026 Earnings Release and Call Nutex Health, a physician-led and fully integrated healthcare delivery organization, has officially announced its plans to release financial results for the first quarter of fiscal year 2026. The company, which operates…
Compass Pathways plc Advances Toward FDA Approval with Rolling NDA Review and Priority Voucher for COMP360 U.S. Food and Drug Administration (FDA) has granted a significant regulatory milestone to Compass Pathways plc, reinforcing the company’s leadership in the emerging field…
Understanding the Hidden Risks of High Blood Pressure It is entirely possible to feel perfectly healthy and still be at serious risk. High blood pressure, medically known as hypertension, is often described as a “silent” condition because it can develop…